{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:08:05Z","timestamp":1789834085070,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573607"],"award-info":[{"award-number":["81573607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202917"],"award-info":[{"award-number":["81202917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2015A020211036"],"award-info":[{"award-number":["2015A020211036"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.yexcr.2020.111980","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T20:01:52Z","timestamp":1585339312000},"page":"111980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the anti-cervical cancer effect of a prodrug \uff1aCBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models"],"prefix":"10.1016","volume":"391","author":[{"given":"Hong-Ce","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Wan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2020.111980_bib1","first-page":"2843","article-title":"Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies","volume":"61","author":"Trouet","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2020.111980_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/pr.56.1.3","article-title":"Enzyme-catalyzed activation of anticancer prodrugs","volume":"56","author":"Rooseboom","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2020.111980_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/bip.21681","article-title":"Enhanced cellular uptake and metabolic stability of lipo-oligoarginine peptides","volume":"96","author":"Lee","year":"2011","journal-title":"Biopolymers"},{"key":"10.1016\/j.yexcr.2020.111980_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/elps.201100455","article-title":"Stability of amyloid-\u03b2 peptides in plasma and serum","volume":"33","author":"Mirko","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.yexcr.2020.111980_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425255.2011.574126","article-title":"Stability of peptides and therapeutic success in cancer","volume":"7","author":"Marl\u00e8ne","year":"2011","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.yexcr.2020.111980_bib6","first-page":"517","article-title":"Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha","volume":"101","author":"Daniel Sd","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2020.111980_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/mp200434n","article-title":"Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug","volume":"9","author":"Liu","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.yexcr.2020.111980_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0014-5793(98)01574-9","article-title":"Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases","volume":"441","author":"Chen","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2020.111980_bib9","doi-asserted-by":"crossref","unstructured":"C.R. Caffrey, M.A. Mathieu, A.M. Gaffney, J.P. Salter, M. Sajid, K.D. Lucas, C. Franklin, M. Bogyo, J.H. McKerrow, Identification of a cDNA encoding an active asparaginyl endopeptidase of Schistosoma mansoni and its expression in Pichia pastoris. FEBS Lett. 466 0-248.","DOI":"10.1016\/S0014-5793(99)01798-6"},{"key":"10.1016\/j.yexcr.2020.111980_bib10","first-page":"24","article-title":"Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile","volume":"68","author":"Dall","year":"2011","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.yexcr.2020.111980_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3727\/096504015X14410238486649","article-title":"Knockdown of legumain suppresses cervical cancer cell migration and invasion","volume":"23","author":"Meng","year":"2016","journal-title":"Oncology Research"},{"key":"10.1016\/j.yexcr.2020.111980_bib12","doi-asserted-by":"crossref","first-page":"16599","DOI":"10.1038\/srep16599","article-title":"Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2020.111980_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/bj3350111","article-title":"Cloning and expression of mouse legumain, a lysosomal endopeptidase","volume":"335","author":"Chen","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2020.111980_bib14","first-page":"10773","article-title":"Legumain protein as a potential predictive biomarker for Asian patients with breast carcinoma","volume":"15","author":"Mei","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention Apjcp"},{"key":"10.1016\/j.yexcr.2020.111980_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2014.10.020","article-title":"High expression of the cysteine proteinase legumain in colorectal cancer \u2013 implications for therapeutic targeting","volume":"51","author":"Haugen","year":"2015","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.yexcr.2020.111980_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/cbdd.12525","article-title":"Synthesis and evaluation of a CBZ-AAN-Dox prodrug and its in vitro effects on SiHa cervical cancer cells under hypoxic conditions","volume":"86","author":"Chen","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.yexcr.2020.111980_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0959-437X(00)00074-5","article-title":"Zebrafish: a model system for the study of human disease","volume":"10","author":"Dooley","year":"2000","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.yexcr.2020.111980_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0031-9384(99)00203-6","article-title":"Animal models of disease","volume":"68","author":"Mccabe","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.yexcr.2020.111980_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/17425250902882128","article-title":"The use of in vivo zebrafish assays in drug toxicity screening","volume":"5","author":"Eimon","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.yexcr.2020.111980_bib20","series-title":"Expression pattern analysis of legumain gene in zebrafish embryonic development. Progress in Veterinary Medicine","author":"Jia","year":"2017"},{"key":"10.1016\/j.yexcr.2020.111980_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/mp200434n","article-title":"Targeting cell surface alpha(v)beta(3) integrins increases therapeutic efficacies of a legumain protease-activated auristatin prodrug","volume":"9","author":"Yuan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.yexcr.2020.111980_bib22","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1016\/j.bmc.2014.04.056","article-title":"Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity","volume":"22","author":"Smith","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.yexcr.2020.111980_bib23","series-title":"The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish( Danio rerio )","year":"2000"},{"key":"10.1016\/j.yexcr.2020.111980_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/bc800448u","article-title":"A novel antitumor prodrug platform designed to Be cleaved by the endoprotease legumain","volume":"20","author":"Stern","year":"2009","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.yexcr.2020.111980_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cmdc.201000478","article-title":"The legumain protease-activated auristatin prodrugs suppress tumor growth and metastasis without toxicity","volume":"6","author":"Bajjuri","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.yexcr.2020.111980_bib26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.febslet.2007.02.064","article-title":"Legumain\/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells","volume":"581","author":"Morita","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2020.111980_bib27","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1172\/JCI27648","article-title":"Targeting tumor-associated macrophages as a novel strategy against breast cancer","volume":"116","author":"Luo","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2020.111980_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00345-012-0977-z","article-title":"Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness","volume":"31","author":"Ohno","year":"2013","journal-title":"World J. Urol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720301956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720301956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:30:28Z","timestamp":1757997028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720301956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0014482720301956"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111980","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the anti-cervical cancer effect of a prodrug \uff1aCBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111980"}}